Phase 2 Trial of Pembrolizumab, Ixazomib, and Dexamethasone for Relapsed Multiple Myeloma
Phase of Trial: Phase II
Latest Information Update: 18 Jan 2019
At a glance
- Drugs Dexamethasone (Primary) ; Ixazomib (Primary) ; Pembrolizumab (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 09 Jan 2019 Status changed from recruiting to suspended.
- 31 Aug 2018 Biomarkers information updated
- 19 Jun 2018 Status changed from not yet recruiting to recruiting.